Evoke intends to continue to expand its pipeline of product candidates in its key focus area of gastroenterology disorders. This will be accomplished by in-licensing or acquiring other drug products and product candidates, with a focus on drugs that utilize novel technologies to improve the profile of previously approved compounds.
Characteristics of opportunities with particular interest include:

  • Programs with associated clinical data
  • Products containing previously approved compounds
  • Considerable exclusivity or intellectual property
  • Gastroenterology focused treatment paradigm

Additionally, Evoke seeks to leverage its capabilities with other development partnerships, commercial organizations and external consultants including other creative relationships.